Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication

Amyloidosis is a disorder of protein misfolding and metabolism in which insoluble fibrils are deposited in various tissues, causing organ dysfunction and eventually death. Out of the 60-plus heterogeneous amyloidogenic proteins that have been identified, approximately 30 are associated with human di...

Full description

Saved in:
Bibliographic Details
Main Author: Kelty R. Baker
Format: Article
Language:English
Published: Houston Methodist DeBakey Heart & Vascular Center 2022-03-01
Series:Methodist DeBakey Cardiovascular Journal
Subjects:
Online Access:https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1070
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850128281778520064
author Kelty R. Baker
author_facet Kelty R. Baker
author_sort Kelty R. Baker
collection DOAJ
description Amyloidosis is a disorder of protein misfolding and metabolism in which insoluble fibrils are deposited in various tissues, causing organ dysfunction and eventually death. Out of the 60-plus heterogeneous amyloidogenic proteins that have been identified, approximately 30 are associated with human disease. The unifying feature of these proteins is their tendency to form beta-pleated sheets aligned in an antiparallel fashion. These sheets then form rigid, nonbranching fibrils that resist proteolysis, causing mechanical disruption and local oxidative stress in affected organs such as the heart, liver, kidneys, nervous system, and gastrointestinal tract. Here we review the epidemiology of light chain amyloidosis, the staging, and the concomitant prognostication that is critical in determining the appropriate treatment.
format Article
id doaj-art-3d41d24670c446019de4f4cd816962e7
institution OA Journals
issn 1947-6108
language English
publishDate 2022-03-01
publisher Houston Methodist DeBakey Heart & Vascular Center
record_format Article
series Methodist DeBakey Cardiovascular Journal
spelling doaj-art-3d41d24670c446019de4f4cd816962e72025-08-20T02:33:23ZengHouston Methodist DeBakey Heart & Vascular CenterMethodist DeBakey Cardiovascular Journal1947-61082022-03-01182273510.14797/mdcvj.1070819Light Chain Amyloidosis: Epidemiology, Staging, and PrognosticationKelty R. Baker0Houston Methodist Hospital, Houston, TexasAmyloidosis is a disorder of protein misfolding and metabolism in which insoluble fibrils are deposited in various tissues, causing organ dysfunction and eventually death. Out of the 60-plus heterogeneous amyloidogenic proteins that have been identified, approximately 30 are associated with human disease. The unifying feature of these proteins is their tendency to form beta-pleated sheets aligned in an antiparallel fashion. These sheets then form rigid, nonbranching fibrils that resist proteolysis, causing mechanical disruption and local oxidative stress in affected organs such as the heart, liver, kidneys, nervous system, and gastrointestinal tract. Here we review the epidemiology of light chain amyloidosis, the staging, and the concomitant prognostication that is critical in determining the appropriate treatment.https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1070light chain amyloidosisprognosismayo clinic staging systemcardiac amyloidosis
spellingShingle Kelty R. Baker
Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
Methodist DeBakey Cardiovascular Journal
light chain amyloidosis
prognosis
mayo clinic staging system
cardiac amyloidosis
title Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
title_full Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
title_fullStr Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
title_full_unstemmed Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
title_short Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
title_sort light chain amyloidosis epidemiology staging and prognostication
topic light chain amyloidosis
prognosis
mayo clinic staging system
cardiac amyloidosis
url https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1070
work_keys_str_mv AT keltyrbaker lightchainamyloidosisepidemiologystagingandprognostication